Salesforce Got Treated Like Dead SaaS. The Numbers Say Otherwise.

The market did not just mark Salesforce down. It reclassified it.

Salesforce (CRM) closed July 8 at $166.58, nearly 40% below its 52-week high and below both major moving averages. The chart says investors have stopped treating Salesforce like premium software. The financials say the company is not broken.

That tension is the setup.

Salesforce just reported $11.13 billion of Q1 FY2027 revenue, up 13% year over year, generated $6.6 billion of free cash flow in the quarter, and guided full-year revenue to $45.9-$46.2 billion. This is not a collapsing SaaS franchise. It is a slower-growth, high-cash-flow enterprise software platform being priced as if AI will permanently compress the model.

The Setup

CRM now trades at 19.2x TTM GAAP earnings, 3.2x sales, and a 10.7% TTM free-cash-flow yield. On management’s FY2027 non-GAAP EPS guidance of $14.06-$14.12, the stock is roughly 11.8x forward non-GAAP earnings.

The punishment is understandable. AI may change how companies buy software. If agents replace support, sales operations, workflow automation and analytics seats, the old SaaS model comes under pressure. Salesforce sits directly in the blast zone of that debate.

But the market may be over-discounting the damage. Salesforce’s Q1 numbers show a business that is still growing, still profitable, and still converting revenue into large cash flows.

The Business Did Not Break

Revenue grew from $21.3 billion in FY2021 to $41.5 billion in FY2026. Management now guides FY2027 revenue to roughly $46.1 billion at the midpoint.

The margin story is even more important. Salesforce produced $8.9 billion of FY2026 operating income and $14.4 billion of free cash flow. Q1 FY2027 GAAP operating margin was 21.1%, while non-GAAP operating margin was 34.8%.

This is where the bear case has to be precise. Salesforce is not losing money to defend a melting platform. It is still producing enough cash to buy back stock, pay a dividend, invest in AI and defend margins.

The buyback is aggressive: Salesforce returned $27.5 billion to shareholders in Q1, including $27.1 billion of repurchases, and entered a $25 billion accelerated share repurchase. That can be smart capital allocation at a depressed price, but it also raised balance-sheet risk. Total debt is now $41.9 billion against $11.8 billion of cash and short-term investments.

The AI Question

The entire stock comes down to one question: does AI reduce Salesforce’s value, or make its customer data and workflow layer more important?

Salesforce is trying to prove the second answer. Agentforce and Data 360 ARR reached nearly $3.4 billion, up more than 200% year over year. Agentforce ARR was $1.2 billion, up 205%, and Salesforce says Agentforce has delivered 3.8 billion Agentic Work Units to date.

Those numbers are early, but they matter because Salesforce already owns the customer data, identity, workflow permissions and enterprise context that AI agents need to operate safely. The bear case says AI destroys seats. The bull case says AI turns Salesforce into the control layer for agentic work.

At the current valuation, CRM does not need the bull case to be perfect. It needs the business to remain relevant.

The Consensus Gap

This is where the price-target discipline flips bullish.

FMP’s 12-month target set shows a $265.75 mean target, $265 median, $325 high and $215 low. From $166.58, the mean target implies 59.5% upside. Even the low target is 29.1% above the current price.

StockAnalysis uses a lower aggregate, with an average target of $246.44, but even that implies roughly 49% upside on its page snapshot. The exact number differs. The conclusion does not: CRM trades far below consensus.

That is why this is a BUY setup, not just a watchlist name.

The Chart Still Matters

The technical picture is damaged. CRM trades below the 50-DMA at $173.60 and the 200-DMA at $211.15. It is only 13.8% above its 52-week low of $146.32.

That means the entry has to be staged:

• Start below $174 if you accept volatility.

• Add above $174 only if the stock reclaims the 50-DMA with volume.

• Add more above $211 if the stock reclaims the 200-DMA and software sentiment improves.

• Stop on a close below $146, the 52-week low.

The Bottom Line

Salesforce has been priced like AI already killed legacy SaaS. The numbers do not support that verdict yet. Revenue is still growing, free cash flow is still large, margins are still high, and the stock now trades at a multiple that gives investors room to be right without needing Salesforce to become a hypergrowth story again.

The risk is real: AI could compress seats, slow growth, and force Salesforce to defend share with lower pricing. But at 11.8x FY2027 non-GAAP EPS guidance and a 10.7% FCF yield, the market is already charging a heavy discount for that risk.

Verdict: BUY / accumulate below the 50-DMA. Target band $215-$266, stretch $325, stop below $146.

This article is a preview of our full flagship Intelligence Report on Salesforce (CRM).

The complete deep-dive adds:

• The full peer table versus NOW, ADBE, ORCL, MSFT and WDAY

• A probability-weighted bull/base/bear scenario map into mid-2027

• Technical levels for the 50-DMA, 200-DMA, 52-week low and target range

• A full risk section on AI disruption, growth reacceleration and debt-funded buybacks

Read the full report on the StockResearch platform:

Stockresearch Platform

StockResearch delivers institutional-grade equity research for investors who want signal, not noise.

Read the full report on the StockResearch platform

Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Equities are volatile and carry risk of loss. All market data is sourced as of the July 8, 2026 U.S. market close unless otherwise stated. The author holds no position in CRM at the time of writing. Always conduct your own due diligence before making investment decisions.